- Home
- WF vs HALO Comparison
WF vs HALO Comparison
Compare WF & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WF
- HALO
- Stock Information
- Founded
- WF 1899
- HALO 1998
- Country
- WF South Korea
- HALO United States
- Employees
- WF N/A
- HALO N/A
- Industry
- WF Commercial Banks
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WF Finance
- HALO Health Care
- Exchange
- WF Nasdaq
- HALO Nasdaq
- Market Cap
- WF 8.7B
- HALO 7.4B
- IPO Year
- WF N/A
- HALO N/A
- Fundamental
- Price
- WF $41.66
- HALO $56.07
- Analyst Decision
- WF
- HALO Buy
- Analyst Count
- WF 0
- HALO 9
- Target Price
- WF N/A
- HALO $63.56
- AVG Volume (30 Days)
- WF 50.1K
- HALO 3.5M
- Earning Date
- WF 07-24-2025
- HALO 05-06-2025
- Dividend Yield
- WF 5.18%
- HALO N/A
- EPS Growth
- WF 19.20
- HALO 55.40
- EPS
- WF 2.49
- HALO 3.76
- Revenue
- WF $7,562,040,413.00
- HALO $1,084,306,000.00
- Revenue This Year
- WF N/A
- HALO $25.77
- Revenue Next Year
- WF $2.09
- HALO $18.01
- P/E Ratio
- WF $5.56
- HALO $14.92
- Revenue Growth
- WF 14.16
- HALO 25.64
- 52 Week Low
- WF $29.44
- HALO $42.01
- 52 Week High
- WF $42.80
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- WF 75.09
- HALO 48.34
- Support Level
- WF $38.58
- HALO $54.00
- Resistance Level
- WF $42.67
- HALO $55.25
- Average True Range (ATR)
- WF 1.21
- HALO 2.53
- MACD
- WF 0.19
- HALO 0.14
- Stochastic Oscillator
- WF 78.89
- HALO 42.01
About WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holdings company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. Its operating segments include Banking, Credit card, capital, Investment banking, and others.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.